ELEVAI Labs Inc. is a California-based medical aesthetic company that develops innovative science-driven topical skincare technologies for the medical dispense market. ELEVAI Skincare™ products were developed under a proprietary “source to skin” technology platform called PREx, Precision Regenerative Exosome Technology™. PREx is based on over 15 years of research and development by stem cell expert and biochemical engineer, Dr. Jordan Plews.
The ELEVAI E-Series™ products, empower and enfinity, were developed to provide both post-treatment skin support and ongoing daily aftercare. Both products contain exosomes; ultra-small, nanoparticle compartments packed with growth factors known to support skin health. The patent pending ELEVAI Exosome™ is the powerhouse ingredient in all ELEVAI products and mimics the elegant repair process of nature along with a selection of high-quality actives to provide ongoing skin health for any skin type.
ELEVAI Skincare products are available in Dermatology, Plastic Surgery, and Professional Medical Spa locations across the US, Canada, and other international markets. We expect continued growth across all markets in 2023-24.
With the discovery of exosome technology and the recent advancement of this research in topical skincare applications, ELEVAI will lead the way by bringing PREx Technology to the professional skincare market revolutionizing how skin concerns related to aging and overall longevity of skin are addressed.
At ELEVAI® we believe this is the future of skincare and skin wellness and we believe that we have the right people, the right technology, and the right timing to take the industry by storm and provide both physicians and consumers with next-generation products that are science-driven, efficacious, and at the leading edge of innovation.
